To view this email as a web page, click here.
 
TOP STORIES
 
Seven Most Out-Of-Reach Drugs for Patients Due to High Costs
Drug costs are increasing, but so is patient cost sharing. That's raising serious problems for some patients. Here are seven of the most out-of-reach drugs due to high costs, according to industry watchers.
Read more
ADVERTISEMENT
 
Three Vaccine Developments Healthcare Execs Should Watch
Vaccines are an important part of creating "herd immunity" to keep infectious diseases in check. Here are three vaccine developments that have far reaching implications for public health.
Read more
ADVERTISEMENT
 
Top Cost Considerations for CAR-T, CRISPR Cancer Treatment
The cost to treat cancer in the United States could reach $156 billion in 2020, according to the National Cancer Institute. And innovative medications have a significant impact on the cost of care.
Read more
 
DIGITAL EDITION
Check out our June issue featuring:
 • Exclusive Pharmacy Survey
 • Right-to-Try Pros and Cons
 • Pharmacy Regs to Watch
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.